These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3260902)

  • 1. Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells.
    Reilly CF; Fritze LM; Rosenberg RD
    J Cell Physiol; 1988 Jul; 136(1):23-32. PubMed ID: 3260902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.
    Reilly CF; Fritze LM; Rosenberg RD
    J Cell Physiol; 1987 May; 131(2):149-57. PubMed ID: 3495540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
    Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
    Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
    Reilly CF
    J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
    Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
    J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
    Roztocil E; Nicholl SM; Galaria II; Davies MG
    Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
    Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
    Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin.
    Okona-Mensah KB; Shittu E; Page C; Costello J; Kilfeather SA
    Br J Pharmacol; 1998 Oct; 125(4):599-606. PubMed ID: 9831891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
    Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
    J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells.
    Bhargava G; Rifas L; Makman MH
    J Cell Physiol; 1979 Aug; 100(2):365-74. PubMed ID: 315948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue.
    Reape TJ; Wilson VJ; Kanczler JM; Ward JP; Burnand KG; Thomas CR
    J Mol Cell Cardiol; 1997 Jun; 29(6):1639-48. PubMed ID: 9220349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells.
    Kayanoki Y; Higashiyama S; Suzuki K; Asahi M; Kawata S; Matsuzawa Y; Taniguchi N
    Biochem Biophys Res Commun; 1999 May; 259(1):50-5. PubMed ID: 10334914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
    Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
    J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques.
    Miyagawa J; Higashiyama S; Kawata S; Inui Y; Tamura S; Yamamoto K; Nishida M; Nakamura T; Yamashita S; Matsuzawa Y
    J Clin Invest; 1995 Jan; 95(1):404-11. PubMed ID: 7814641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet-derived growth factor, insulin-like growth factor-I, and epidermal growth factor.
    Yamamoto M; Yamamoto K
    Exp Cell Res; 1994 May; 212(1):62-8. PubMed ID: 8174643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors.
    Cohick WS; Gockerman A; Clemmons DR
    J Cell Physiol; 1993 Oct; 157(1):52-60. PubMed ID: 7691836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
    Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
    J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells.
    Lockyer JM; Bowden GT; Matrisian LM; Magun BE
    Cancer Res; 1981 Jun; 41(6):2308-14. PubMed ID: 6972249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.